BTTX (Better Therapeutics) Total Liabilities: $20.66 Mil (As of Sep. 2023)


What is Better Therapeutics Total Liabilities?

Better Therapeutics BTTX Total Liabilities is $20.66 Mil as of Sep. 2023.

Better Therapeutics's Total Liabilities for the quarter that ended in Sep. 2023 was $20.66 Mil.

Better Therapeutics's quarterly Total Liabilities declined from Mar. 2023 ($22.64 Mil) to Jun. 2023 ($22.39 Mil) and declined from Jun. 2023 ($22.39 Mil) to Sep. 2023 ($20.66 Mil).

Better Therapeutics's annual Total Liabilities increased from Dec. 2020 ($13.15 Mil) to Dec. 2021 ($14.24 Mil) and increased from Dec. 2021 ($14.24 Mil) to Dec. 2022 ($23.84 Mil).

Better Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics Total Liabilities Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Liabilities
5.49 13.15 14.24 23.84

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.97 23.84 22.64 22.39 20.66

Better Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Better Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.494+(10.348+-1.7763568394003E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=23.84

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=22.943--0.899
=23.84

Better Therapeutics's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12.938+(7.721+-1.7763568394003E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=20.66

Total Liabilities=Total Assets (Q: Sep. 2023 )-Total Equity (Q: Sep. 2023 )
=10.722--9.937
=20.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $20.66 Mil mean?
Better Therapeutics (BTTX) has a Total Liabilities of $20.66 Mil as of Sep. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Better Therapeutics and its competitors.
Is Better Therapeutics' Total Liabilities too high?
Better Therapeutics' current Total Liabilities is $20.66 Mil.
How does Better Therapeutics' Total Liabilities compare to CYCN and CELZ?
Better Therapeutics' Total Liabilities of $20.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Better Therapeutics and its competitors. Better Therapeutics's current Total Liabilities is $20.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current Total Liabilities of $20.66 Mil. The current Total Liabilities is $20.66 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current Total Liabilities is $20.66 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.